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Modification of proteins with the 76 amino acid protein ubiquitin plays essential roles in
cellular signaling. Development of methods for specific enrichment of ubiquitin remnant
peptides and advances in high-resolution mass spectrometry have enabled proteome-
wide identification of endogenous ubiquitylation sites. Moreover, ubiquitin remnant
profiling has emerged as a powerful approach for investigating changes in protein
ubiquitylation in response to cellular perturbations, such as DNA damage, as well as
for identification of substrates of ubiquitin-modifying enzymes. Despite these advances,
interrogation of ubiquitin chain topologies on substrate proteins remains a challenging
task. Here, we describe mass spectrometry-based approaches for quantitative analyses
of site-specific protein ubiquitylation and highlight recent studies that employed these
methods for investigation of ubiquitylation in the context of the cellular DNA damage
response. Furthermore, we provide an overview of experimental strategies for probing
ubiquitin chain topologies on proteins and discuss how these methods can be applied
to analyze functions of ubiquitylation in the DNA damage response.
Keywords: mass spectrometry-based proteomics, ubiquitin, ubiquitin-modifying enzymes, ubiquitin remnant
profiling, DNA damage response
MASS SPECTROMETRY-BASED PROTEOMICS FOR
INVESTIGATING POSTTRANSLATIONAL MODIFICATIONS
Mass spectrometry (MS)-based proteomics has become a powerful tool for investigating
posttranslational modifications (PTMs) of proteins in the context of cellular signaling (Larance and
Lamond, 2015). In shotgun or bottom up proteomics, cellular proteins are subjected to proteolysis
and the resulting peptides are separated according to hydrophobicity using high-pressure liquid
chromatography (LC) and identified by tandem mass spectrometry (LC–MS/MS; Aebersold and
Mann, 2003). The mass difference introduced by the presence of PTMs can be exploited for
identification and localization of modifications. A major obstacle for proteome-wide analysis of
posttranslational modification sites by LC–MS/MS is the sub-stoichiometric cellular occurrence of
modified protein species and the inability of current mass spectrometers to identify all peptides
resulting from digestion of the cellular proteome. Consequently, specific enrichment methods for
modified peptide species are essential for the proteome-wide identification of PTMs by LC-MS/MS.
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Identification of endogenous ubiquitylation sites by MS-
based proteomics has long been hampered by a lack of
specific enrichment methods for ubiquitylated peptides.
Earlier studies have most commonly relied on the ectopic
expression of polyhistidine tagged ubiquitin and enrichment of
ubiquitylated proteins by nickel-nitrilotriacetic acid (Ni-NTA)
chromatography under denaturing conditions. Alternatively,
purified tagged ubiquitin-binding domains have been used to
enrich ubiquitylated proteins from cells expressing endogenous
ubiquitin (Hjerpe et al., 2009). These approaches have been
successfully employed for the identification of putative
ubiquitylated proteins and a limited number of ubiquitylation
sites (Peng et al., 2003; Matsumoto et al., 2005; Tagwerker
et al., 2006; Meierhofer et al., 2008; Danielsen et al., 2011).
However, enrichment at the protein level does not sufficiently
reduce sample complexity and thus does not permit efficient
proteome-wide identification of endogenous ubiquitylation sites.
UBIQUITIN REMNANT PROFILING FOR
PROTEOME-WIDE IDENTIFICATION OF
UBIQUITYLATION SITES
Digestion of ubiquitylated proteins with trypsin leaves a di-
glycine remnant from the C-terminus of ubiquitin covalently
attached to the previously ubiquitylated lysine. The di-glycine
remnant leads to a peptide mass shift (∼114 Da) and can
be exploited to pinpoint the localization of the ubiquitin
attachment site in the protein (Peng et al., 2003) (Figure 1).
Xu et al. (2010) used di-glycine-modified histones as an antigen
to produce the monoclonal antibody GX41 that specifically
recognizes di-glycine adducts on the ε-amine of lysine. To
demonstrate the applicability of the antibody for enrichment of
di-glycine modified peptides, the authors purified ubiquitylated
proteins from HEK293T cells ectopically expressing His6-tagged
ubiquitin. After proteolysis, di-glycine-modified peptides were
enriched using di-glycine lysine specific antibodies and identified
by LC–MS/MS.
The generation of di-glycine lysine specific antibodies and
advances in high-resolution mass spectrometry have enabled
first proteome-wide studies of endogenous ubiquitylation sites in
human cells (Kim et al., 2011; Wagner et al., 2011) (Figure 1).
Wagner et al. (2012) extended ubiquitin remnant profiling to
murine tissues and demonstrated that different tissues display
specific ubiquitylation patterns. In addition, they identified a
number of core ubiquitylation sites that are present in all
examined tissues.
One drawback of ubiquitin remnant profiling is that tryptic
digestion of proteins modified with the ubiquitin-like modifiers
NEDD8 and ISG15 also results in a di-glycine remnant attached
to the previously modified lysine. Consequently, ubiquitin
remnant profiling does not allow distinguishing NEDD8- and
ISG15-modification sites from ubiquitylation sites. However,
the expression of ISG15 in cells that are not stimulated with
interferon (IFN)-α/β is very low (Skaug and Chen, 2010) and
NEDD8 is considered to primarily modify Cullin-RING ligases
(CRLs; Lydeard et al., 2013). Kim et al. (2011) used different
experimental approaches to demonstrate that >94% of the di-
glycine lysine containing peptides are indeed ubiquitin remnant
peptides.
QUANTITATIVE ANALYSES OF PROTEIN
UBIQUITYLATION BY UBIQUITIN
REMNANT PROFILING
Ubiquitin remnant profiling can be combined with quantitative
proteomics approaches based on metabolic (e.g., stable isotope
labeling with amino acids in cell culture, SILAC) or chemical
labeling (e.g., tandem mass tags or isobaric tags for relative
and absolute quantitation) to quantify the relative abundance
of ubiquitylation sites in different experimental conditions. In
the last 5 years this strategy has been successfully implemented
to investigate site-specific alterations of the ubiquitin-modified
proteome after cellular stress or growth factor stimulation as well
as to identify substrates of ubiquitin-modifying enzymes.
Initial studies employed ubiquitin remnant profiling and
SILAC-based quantitative proteomics to analyze site-specific
changes in ubiquitylation in different human cell lines after
inhibition of the proteasome (Kim et al., 2011; Wagner et al.,
2011; Udeshi et al., 2012). These studies have shown that
proteasome inhibition globally perturbs cellular ubiquitylation
patterns and leads to increased ubiquitylation of >40% of the
quantified sites. Interestingly, proteasome inhibition also results
in decreased abundance of a fraction of ubiquitylation sites,
including sites on histones and DNA repair factors PCNA,
FANCI, and FANCD2 that confer non-degradative, regulatory
functions. These observations indicate that proteasome
inhibition leads to depletion of the cellular ubiquitin pool
and results in a shift from mono- to poly-ubiquitylation, and
can therefore be used to distinguish degradative from non-
degradative, regulatory ubiquitylation (Kim et al., 2011; Wagner
et al., 2011; Udeshi et al., 2012; Higgins et al., 2015).
Ubiquitin remnant profiling and SILAC-based quantitative
proteomics has been used to perform first proteome-wide, site-
specific analyses of ubiquitylation after DNA damage. Povlsen
et al. (2012) induced DNA damage in U2OS cells by ultraviolet
light (UV) irradiation and identified up-regulated and down-
regulated ubiquitylation sites on known components of DNA
damage repair and signaling as well as on proteins that had
not been previously implicated in this process, demonstrating
that ubiquitin-modifying enzymes play an integral role in the
regulation of the cellular response to DNA damage. This study
also demonstrated that UV light affects the ubiquitylation
status of the PCNA-associated factor PAF15 and that PAF15
ubiquitylation regulates the interaction between translesion
synthesis polymerases and PCNA during the DNA damage
bypass. Another study investigated site-specific changes in
ubiquitylation after DNA damage induced by irradiation of
U2OS cells with UV light or ionizing radiation (IR) and could
demonstrate that centromere proteins are de-ubiquitylated in
response to UV light- and IR-induced DNA damage (Elia et al.,
2015a). Notably, in this study profiling of ubiquitylation sites
has been performed with and without pre-treatment of cells with
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FIGURE 1 | MS-based proteomics approaches for analyzing protein ubiquitylation. (A) Digestion of ubiquitylated proteins with trypsin leaves a di-glycine
remnant from the C-terminus of ubiquitin covalently attached to the previously modified lysine. (B) Exemplary fragment spectrum of a di-glycine modified peptide.
The di-glycine remnant leads to a shift of ∼114 Da in the peptide mass and can be exploited to pinpoint the localization of the ubiquitin attachment. (C) For ubiquitin
remnant profiling, proteins extracted from cells are digested into peptides using trypsin, di-glycine modified peptides are enriched using di-glycine lysine specific
antibodies and identified by LC-MS/MS. ∗Pre- and post-enrichment fractionation can be introduced to decrease sample complexity and increase the depth of the
analysis. For ubiquitin chain topology profiling, proteins extracted from cells or tissues are incubated with an ubiquitin linkage-specific binder (e.g., antibody, affimer,
TUBE). Enriched proteins modified by a specific type of ubiquitin chain are digested in-gel into peptides and peptide samples are analyzed by LC-MS/MS.
∗Post-enrichment fractionation can be introduced to decrease sample complexity and increase the depth of the analysis.
the proteasome inhibitor MG132 to facilitate the identification of
both degradative and non-degradative, regulatory ubiquitylation
sites, respectively. In another study, the same authors found that
the single-stranded DNA binding protein RPA is ubiquitylated
on multiple lysines after replication fork stalling by the ubiquitin
ligase RFWD3 (Elia et al., 2015b). Ubiquitylation of RPA occurs
on chromatin and does not mediate its degradation, but is
important for the replication fork restart and homologous
recombination at stalled replication forks.
Ubiquitin remnant profiling also enables global analyses of
ubiquitin-linkage abundance and has been employed to reveal
that UV light irradiation increases the cellular abundance of K6-
linked ubiquitin chains (Povlsen et al., 2012; Elia et al., 2015a).
Modification of proteins with K6-linked ubiquitylation by the
ubiquitin ligase BRCA1 has been previously suggested to play a
role in the cellular response to DNA damage (Wu-Baer et al.,
2003, 2010; Morris and Solomon, 2004; Nishikawa et al., 2004).
Ubiquitin remnant profiling is a powerful approach for
identification and quantification of ubiquitylation sites, however,
several limitations should be considered when designing
experiments: shotgun proteomics is biased towards more
abundant peptide species and it is likely that ubiquitylation
sites on low abundant, chromatin-associated proteins that often
play an essential role in the regulation of DNA damage repair
and signaling are missed. Also, the high amount of protein
that is needed in order to achieve a satisfactory depth of the
analysis hampers the application of this method for samples
with limited quantity (e.g., primary cells). We envision that
further improvements of MS instrumentation will facilitate the
identification and quantification of low abundant ubiquitylation
sites. Alternatively, targeted proteomics approaches can be




In addition to analyzing ubiquitin-dependent processes after
DNA damage, an increasing number of studies have successfully
employed ubiquitin remnant profiling and quantitative
proteomics to identify substrates of ubiquitin ligases and
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FIGURE 2 | Experimental strategy for analyzing DNA damage-associated ubiquitylation. Cells are metabolically labeled using heavy isotope containing
lysine and arginine (SILAC) and subsequently treated with a DNA damage-inducing agent. Pretreatment with an inhibitor or knockdown of ubiquitin-modifying
enzyme can be performed before treatment with the DNA damage-inducing agent. Proteins are extracted from cells and ubiquitylation is quantitatively investigated
using ubiquitin remnant profiling and/or ubiquitin chain topology profiling.
deubiquitylating (DUBs) enzymes. In most studies the activity
of the ubiquitin-modifying enzyme is inhibited using small
molecules or the expression of the enzyme is down-regulated
using knockdown or knockout approaches. Emanuele et al.
(2011) employed ubiquitin remnant profiling and SILAC-based
quantitative proteomics to quantify ubiquitylation sites in
cells in which CRLs activity had been chemically inhibited
by the NEDD8-activating enzyme inhibitor MLN4924. CRLs
frequently target substrate proteins for degradation through
the proteasome and therefore additional pre-treatment of cells
with the proteasome inhibitor had been used to stabilize the
proteins that are normally targeted for degradation by CRLs.
The authors identified hundreds of ubiquitylation sites that
decreased in abundance after CRL inhibition and demonstrated
that NUSAP1, a protein involved in mitosis and DNA damage
response, is a novel substrate of the Skp1, Cullin, F-box (SCF)
Cyclin F (Emanuele et al., 2011). Elia et al. (2015a) employed a
similar approach to demonstrate that 10% of UV light-induced
ubiquitylation is dependent on CRLs and to show that SCF–
Cyclin F ubiquitylates the double-stranded DNA exonuclease
EXO1 after irradiation of cells with UV light.
Mutations in the substrate recognition domain of the CRL
CUL3 adaptor speckle-type POZ protein (SPOP) are frequently
found in primary prostate cancer (Barbieri et al., 2012). SPOP
functions in DNA double strand break repair and SPOP
mutations in prostate cancer are associated with genomic
instability (Boysen et al., 2015). However, the identity of its
substrates and whether or not cancer-associated mutations of
SPOP affect the substrate landscape remained unclear. Theurillat
et al. (2014) compared the abundance of ubiquitylation sites in
immortalized prostate epithelial cells stably overexpressing wild
type or mutant forms of SPOP. They were able to show that
SPOP mutants lead to decreased ubiquitylation and impaired
degradation of the chromatin remodeler DEK and thereby
contribute to the oncogenic phenotype of prostate cancer cells.
Ubiquitin remnant profiling has also been employed to
identify the substrates of the CRL adaptor cereblon (CRBN).
Krönke et al. (2014) employed a chemical proteomics approach
to show that lenalidomide, a thalidomide derivative used in
treatment of multiple myeloma, binds to CRBN. Following up
on this observation, they employed SILAC-based quantitative
proteomics and ubiquitin remnant profiling to analyze alterations
in ubiquitylation site abundance after treatment of MM1S
multiple-myeloma cell line with lenalidomide. The authors
demonstrated that lenalidomide regulates ubiquitylation and
abundance of the transcription factors IKZF1 and IKZF3, and
could further show that depletion of these proteins inhibited the
growth of lenalidomide-sensitive multiple myeloma cell lines,
while not having an effect on lenalidomide-insensitive cells
(Krönke et al., 2014).
Furthermore, ubiquitin remnant profiling and inducible
knockdown has been employed to identify DNA damage-
inducible transcript 4 (DDIT4) as a novel substrate of the
ubiquitin ligase HUWE1 that has been implicated in cancer
development and DNA damage response (Thompson et al.,
2014).
The above-mentioned studies demonstrate that ubiquitin
remnant profiling is a powerful approach for identifying
substrates of ubiquitin-modifying enzymes in the context of DNA
damage signaling and disease. Development of novel specific
small molecule inhibitors of ubiquitin-modifying enzymes as
well as generation of knockdown/knockout cell lines will help
to further decipher the complex relations between ubiquitin-
modifying enzymes and their substrates.
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INVESTIGATING UBIQUITIN CHAIN
TOPOLOGY
The role of K48-linked ubiquitylation in the degradation of
proteins through the proteasome and the function of K63-
linked ubiquitylation in cellular signaling are well established
(Hochstrasser, 1995; Haglund and Dikic, 2005). The cellular
functions of atypical ubiquitin chains formed through K6,
K11, K27, K29, and K33 are largely unknown and tools for
detection and enrichment of proteins modified with these
atypical ubiquitin chains are missing.
The development of linkage-specific antibodies for M1-, K48-,
and K63-linked ubiquitin chains facilitated the identification
of substrates and functions of these ubiquitin chains (Newton
et al., 2008; Matsumoto et al., 2010, 2012). Recently, high
affinity binders (affimers) for K6, K33, and K48 ubiquitin chains
have been generated and are commercially available; however,
the application of these ubiquitin linkage-specific affimers for
enrichment of proteins modified by specific ubiquitin chains still
remains to be demonstrated. Efficient enrichment of proteins
modified with a particular ubiquitin chain would enable their
identification by LC–MS/MS and greatly help to deepen the
understanding of the cellular functions of atypical ubiquitin
chains (Figure 1).
In addition to antibodies and affimers, the identification of
ubiquitin-binding domains (UBDs) that recognize specific type
of ubiquitin chains allowed generation of engineered tandem
ubiquitin-binding entities (TUBEs) that can be used as affinity
matrix for enrichment of proteins modified with specific types
of ubiquitin chains (Hjerpe et al., 2009; Sims et al., 2012).
Recently, a K63-specific TUBE and SILAC-based quantitative
proteomics have been used to compare protein ubiquitylation
in wild type and UBC13 knockout HCT116 cells. Using this
strategy, Thorslund et al. (2015) identified 371 proteins, several
of which had been previously reported to be modified by
K63-linked ubiquitylation. To complement these results, the
same authors employed a similar approach for identification of
proteins with increased K63-linked ubiquitylation after DNA
damage induced by IR, thus identifying histone H1 as substrate
of UBC13/RNF8 at DNA double strand breaks (Thorslund et al.,
2015). Another study conducted in Saccharomyces cerevisiae
employed a K63-specific TUBE for enrichment of K63-linked
ubiquitylated proteins from wild type and ubiquitin K63R strain
after oxidative stress induced by H2O2. The authors identified
>100 proteins modified with K63-linked ubiquitin chains after
treatment of cells with H2O2 and demonstrated that ribosomal
proteins are dynamically modified by K63-linked ubiquitylation
during the cellular response to H2O2 (Silva et al., 2015). Besides
above mentioned TUBEs for K63-linked ubiquitin chains, TUBEs
specifically binding to M1- and K48-linked ubiquitin chains
have been generated (Trempe et al., 2005; Rahighi et al.,
2009).
Another approach for analyzing ubiquitin chain topology on
substrate proteins has been developed in the Komander lab:
In Ubiquitin Chain Restriction Enzyme Analysis (UbiCRest),
the relative SDS–PAGE mobility of investigated proteins before
and after treatment with different linkage-specific DUBs is
monitored to identify the type of ubiquitin chains on the protein
(Hospenthal et al., 2015). Multiple DUBs from the human
ovarian tumor (OTU) DUB family that display various degrees
of specificities towards different ubiquitin linkage types have
been identified and can be used for UbiCRest: For instance,
OTUB1 specifically cleaves K48-, OTUD1 K63-, Cezanne K11-,
and OTULIN M1-linked ubiquitylation, whereas OTUD3
displays specificity towards K6- and K11-linked ubiquitylation
(Mevissen et al., 2013). A current limitation of this method is
that DUBs might display various specificities towards ubiquitin
chains linkages depending on the set-up of the assay and
the concentration of the enzyme used, and the fact that
specific DUBs for all types of ubiquitin chains have not been
unambiguously identified. To date, UbiCRest was only employed
to study the ubiquitin chain topology on single proteins;
however, it might be possible to combine this method with
MS to identify ubiquitin chain topologies on a proteome-wide
scale.
CONCLUSION
Development of methods for specific enrichment of ubiquitin
remnant peptides and advances in high-resolution MS have
enabled proteome-wide identification of ubiquitylation sites in
cell lines and tissues. Furthermore, ubiquitin remnant profiling
has been used for quantitative analysis of site-specific protein
ubiquitylation after cellular perturbations, thereby providing a
better understanding of the regulatory scope of ubiquitylation in
different cellular processes, including the DNA damage response.
Ubiquitin remnant profiling has also been successfully employed
to identify substrates of ubiquitin-modifying enzymes, some of
which have been implicated in the cellular response to DNA
damage.
However, our understanding of the roles of ubiquitylation
in the cellular DNA damage response is far from complete:
little is known about the function of many of the dynamically
modified ubiquitylation sites identified in ubiquitin remnant
profiling studies. In addition, numerous ubiquitin-modifying
enzymes have been implicated in the DNA damage response
and for most of these enzymes the cellular substrate spectrum
remains to be uncovered. Future studies employing ubiquitin
remnant profiling and novel small molecule inhibitors or
genetic knockdown/knockout approaches are likely to deepen
the knowledge about the substrates and functions of these DNA
damage-associated ubiquitin-modifying enzymes (Figure 2).
Another major challenge lies in the investigation of the
ubiquitin chain topology on proteins. In the last years,
specific binders for M1-, K48- and K63-linked ubiquitin
chains have been developed. Further development of tools
for detection and enrichment of proteins modified with
K6-, K11-, K27-, K29-, and K33-linked ubiquitin chains is
essential to understand the cellular functions of atypical
ubiquitylation. Probing the ubiquitin chain topology on proteins
with DNA damage-regulated ubiquitylation sites will also help to
understand the functions of ubiquitylation in the DNA damage
response (Figure 2).
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